Search - tctmd.com

Displaying 81 - 100 of 4502

Sort: Relevancy | Date

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Presentation TCT 2025

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Presenter: Pushan Aggarwal

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

TCT 763: Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights from a Real-World Cohort

Presenter: Faysal Massad

October 27, 2025

Presentation TCT 2025

TCT 765: Renin-Angiotensin Inhibition Following TAVR: A Fresh Look at Old Allies — An Updated Meta-Analysis

Presenter: Paulo Roberto Tartuce Filho

October 27, 2025

Presentation TCT 2025

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

Presenter: Ritu Yadav

October 27, 2025

Presentation TCT 2025

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

Presenter: Hasan Munshi

October 27, 2025

Presentation TCT 2025

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

Presenter: Frédéric Beaupré

October 27, 2025

Presentation TCT 2025

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

Presenter: Gabriela Tirado-Conte

October 27, 2025

Presentation TCT 2025

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

Presenter: Noah Tregobov

October 27, 2025

Presentation TCT 2025

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

Presenter: Salman Zahid

October 27, 2025

Presentation TCT 2025

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

Presenter: Himanshi Banker

October 27, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

Presenter: Richard Tan

October 26, 2025

Presentation TCT 2025

TCT 773: Efficacy and Clinical outcomes of Human Hepatocyte Growth Factor(HHGF) Plasmid in Critical Limb Ischemia(CLI): A Systematic Review and Meta Analysis

Presenter: Ananya Prasad

October 26, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 26, 2025

Presentation TCT 2025

TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 26, 2025

Advertisement

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

TCT 710: Plug It or Drug It? Left Atrial Appendage Occlusion vs Direct Acting oral Anticoagulants: A Propensity Matched Real World Analysis of 5-year Outcomes for patients with Atrial Fibrillation

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

TCT 760: SGLT2 Inhibitors Reduce Acute Kidney Injury and Improve Survival in Diabetic Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 763: Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights from a Real-World Cohort

TCT 765: Renin-Angiotensin Inhibition Following TAVR: A Fresh Look at Old Allies — An Updated Meta-Analysis

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

TCT 758: Lp(a) and Oxidized Phospholipids as Predictors of Bioprosthetic Valve Dysfunction Following Transcatheter Aortic Valve Implantation

TCT 759: Use of Amiodarone for Prevention of New-Onset Atrial Fibrillation after Transcatheter Aortic Valve Replacement: PAF-TAVR Randomized Clinical Trial

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

TCT 755: Impact of SGLT2 Inhibitors on Outcomes After TAVR: A Real-World Propensity-Matched Analysis

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

TCT 773: Efficacy and Clinical outcomes of Human Hepatocyte Growth Factor(HHGF) Plasmid in Critical Limb Ischemia(CLI): A Systematic Review and Meta Analysis

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content